A phase 2 study of nanoparticle albumin‐bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma

Abstract

The combination of nab-paclitaxel plus NDP for the treatment of patients with late-stage, recurrent, or metastatic cervical cancer appears to be active and tolerable. Cancer 2017;123:420-425. © 2016 American Cancer Society.